Hardy Alexander 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed Dec 2, 2025
Insider Transaction Report
Form 4
Hardy Alexander
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2025-04-30$54.14/sh+375$20,301→ 175,958 total - Tax Payment
Common Stock
2025-12-01$55.03/sh−16,570$911,847→ 159,388 total
Footnotes (1)
- [F1]Represents the shares acquired by the reporting person on April 30, 2025, pursuant to the issuer's Employee Stock Purchase Plan.